I was kindof thinking Friday this week or Tuesday at the latest next week. IMHO Glad we had the measurement markers last year of the Cubist and Durata Therapeutics deals while B-ABSSSI is performing well. And these new B indications starting at phase 2. Thankful again for the news today!